SMPD1 and chronic obstructive pulmonary disease: The results revealed significantly elevated plasma levels of MMP12 and ASM, and significantly reduced levels of NPNT and SNX1 in COPD patients compared to healthy controls (Figure 4), consistent with directions predicted by genetic analyses.